Illumina Raises Full-Year Outlook on Solid Q3 Performance Underpinned by Consumables Sales
Published . Updated .
This report does not map to a usual set of affected companies.
Directly affected
- ILMN Illumina+39.1% 30d
Named in this report.
Indirectly affected
- XLI Industrial Select Sector SPDR+0.2% 30d
Industrial Select Sector SPDR holds the industrials sector that Illumina belongs to, so it often moves with news about it.
- A Agilent Technologies+15.8% 30d
Agilent Technologies is a peer of Illumina in laboratory analytical instruments; rivals often move on the same news.
- WAT Waters+17.0% 9d
Waters is a peer of Illumina in laboratory analytical instruments; rivals often move on the same news.
- RVTY Revvity
Revvity is a peer of Illumina in laboratory analytical instruments; rivals often move on the same news.
- AVTR Avantor
Avantor is a peer of Illumina in laboratory analytical instruments; rivals often move on the same news.
- BIO Bio-Rad Laboratories+2.8% 14d
Bio-Rad Laboratories is a peer of Illumina in laboratory analytical instruments; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ILMN | -7.04% | -3.54% | base | -12.09% | after close | after close | after close |
| XLINo price data for this ticker | — | — | — | — | — | — | — |
| ANo price data for this ticker | — | — | — | — | — | — | — |
| WATNo price data for this ticker | — | — | — | — | — | — | — |
| RVTYNo price data for this ticker | — | — | — | — | — | — | — |
| AVTRNo price data for this ticker | — | — | — | — | — | — | — |
| BIONo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Illumina Raises Full-Year Outlook on Solid Q3 Performance Underpinned by Consumables Sales GenomeWeb
Source: GenomeWeb
This story
| Company | When | Move | Status |
|---|---|---|---|
| ILMN | that day | -12.09% | still updating |
| ILMN | three days earlier | -3.54% | final price |
| ILMN | five days earlier | -7.04% | final price |
Congressional trades in the stocks in this story
- Rep. Kevin Hern sold Waters (WAT) (jointly held), worth $1,001 - $15,000 on 13 Aug 2026. That is 78 days before publication. Filed 1 Sep 2026. View the filing.
- Rep. Gilbert Cisneros sold Revvity (RVTY), worth $15,001 - $50,000 on 9 Sep 2026. That is 51 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Gilbert Cisneros sold Revvity (RVTY), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Gilbert Cisneros sold Revvity (RVTY), worth $1,001 - $15,000 on 3 Sep 2026. That is 57 days before publication. Filed 12 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100Price not final
“Illumina Raises Full-Year Outlook on Solid Q3 Performance Underpinned by Consumables Sales” scores 12 out of 100. The score uses 1 sources. The price is not final yet.